Related Experiment Video
Updated: May 26, 2025

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Circulating exosomes in pediatric obstructive sleep apnea with or without neurocognitive deficits and their effects
Trupti Joshi1, Yen On Chan1, Zhuanhong Qiao2
1MU Institute for Data Science and Informatics, University of Missouri, Columbia, MO, USA; Christophers S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Insights
Exosomes from children with obstructive sleep apnea (OSA) and cognitive deficits disrupt the blood-brain barrier (BBB). This highlights a potential mechanism for neurocognitive issues in pediatric OSA, paving the way for targeted therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Pediatrics
Background:
- Obstructive sleep apnea (OSA) in children is associated with cognitive impairments.
- Blood-brain barrier (BBB) dysfunction is a potential mechanism linking OSA to neurocognitive deficits.
- Exosomes, released by cells, carry molecular cargo reflecting cellular states.
Purpose of the Study:
- To investigate the impact of exosomes from children with OSA, with or without cognitive deficits, on neurovascular unit (NVU) models.
- To assess how these exosomes affect BBB integrity, permeability, and angiogenesis.
- To identify intercellular signaling pathways involved using single-nucleus RNA sequencing (snRNA-seq).
Main Methods:
- Plasma exosomes were isolated from three groups of children: healthy controls, OSA without cognitive deficits (OSA-NG), and OSA with neurocognitive deficits (OSA-POS).
- Exosomes were applied to human 3D NVU spheroids and monolayer/microfluidic BBB models.
- Barrier integrity (TEER, ZO1 staining), permeability, and angiogenesis (tube formation) were measured.
- snRNA-seq and CellChat analysis were performed to identify signaling pathways.
Main Results:
- Exosomes from OSA-POS children significantly disrupted BBB integrity (reduced TEER, impaired ZO1 staining) in 3D NVU spheroids.
- Both OSA-POS and OSA-NG exosomes increased BBB permeability in NVU cell models.
- snRNA-seq revealed distinct cell clusters and intercellular communication pathways specific to the OSA groups.
Conclusions:
- Exosomes from children with OSA, particularly those with cognitive deficits, can impair BBB function.
- The 3D NVU spheroid model is effective for studying exosome effects on the BBB.
- Integrating exosome analysis with snRNA-seq can elucidate mechanisms of neurocognitive dysfunction in pediatric OSA, aiding personalized treatment strategies.
Abstract:
Obstructive sleep apnea (OSA) in children is linked to cognitive impairments, potentially due to blood-brain barrier (BBB) dysfunction. Exosomes, small vesicles released by most cells, reflect cellular changes. This study examined the effects of exosomes from children with OSA, with or without cognitive deficits, on neurovascular unit (NVU) models. Twenty-six children were categorized into three groups: healthy controls (Cont, n = 6), OSA without cognitive deficits (OSA-NG, n = 10), and OSA with neurocognitive deficits (OSA-POS, n = 10). Plasma exosomes were characterized and applied to human 3D NVU spheroids for 24 h. Barrier integrity, permeability, and angiogenesis were assessed using trans-endothelial electrical resistance (TEER), tight junction integrity, and tube formation assays. Single-nucleus RNA sequencing (snRNA-seq) and bioinformatics, including CellChat analysis, identified intercellular signaling pathways. Results showed that exosomes from OSA-POS children disrupted TEER, increased permeability, and impaired ZO1 staining in spheroids, compared to the other groups. Both OSA-POS and OSA-NG exosomes increased permeability in NVU cells in monolayer and microfluidic BBB models. snRNA-seq analysis further revealed distinct cell clusters and pathways associated with the different groups. This 3D NVU spheroid model provides a robust platform to study BBB properties and the role of exosomes in OSA. These findings suggest that integrating snRNA-seq with exosome studies can uncover mechanisms underlying neurocognitive dysfunction in pediatric OSA, potentially leading to personalized therapeutic approaches.

